Matches in Nanopublications for { ?s ?p "[To be eligible, every study had to include the assessment of the LVD or the expression of vascular endothelial growth factor (VEGF)-C or -D in patients with breast cancer and provide a survival comparison, including disease-free survival (DFS) or overall survival (OS), according to the LVD, VEGF-C or VEGF-D status.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP1019756.RAOx_KZJgNJxaAoGe6JpPleHdmXPpu15DX8URyemJ5jws130_assertion description "[To be eligible, every study had to include the assessment of the LVD or the expression of vascular endothelial growth factor (VEGF)-C or -D in patients with breast cancer and provide a survival comparison, including disease-free survival (DFS) or overall survival (OS), according to the LVD, VEGF-C or VEGF-D status.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1019756.RAOx_KZJgNJxaAoGe6JpPleHdmXPpu15DX8URyemJ5jws130_provenance.
- NP1019752.RA7b5pGBNJ7GJ9i2BUH_gthqzkDMu0X3yPxA2_A117o1w130_assertion description "[To be eligible, every study had to include the assessment of the LVD or the expression of vascular endothelial growth factor (VEGF)-C or -D in patients with breast cancer and provide a survival comparison, including disease-free survival (DFS) or overall survival (OS), according to the LVD, VEGF-C or VEGF-D status.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1019752.RA7b5pGBNJ7GJ9i2BUH_gthqzkDMu0X3yPxA2_A117o1w130_provenance.